AAN News & Opinion
- The long-term care (LTC) sector is a major component of the U.S. health care system that continues to grow (Bureau of Labor Statistics, 2014; Congressional Budget Office, 2013). Most of this increase is due to growth in the population of oldest adults (85+), a group with limited capacity for self-care due to health conditions (Congressional Budget Office, 2013; NIA, 2015). In 2014, there were over 46 million Americans 65+ years, and 6.2 million 85+ years old (Federal Interagency Forum on Aging-Related Statistics, 2016).
- Health care organizations worldwide strive to deliver safe, high-quality, patient-centered care while fostering a proficient nursing staff and maintaining fiscal accountability. To achieve these aims, these organizations promote innovation at various organizational levels and in various domains (Drach-Zahavy, Somech, Granot, & Spitzer, 2004; Kaya, Turan, & Aydın, 2015; Länsisalmi, Kivimäki, Aalto, & Ruoranen, 2006; Weng, Huang, Chen, & Chang, 2015). It is increasingly recognized that nurse champions, namely excellent front-line practitioners, come from within the organization and are passionate about improving quality of care, and serving as key agents in implementing innovation via self-developed or management-developed projects (Byers, 2017; McSherry & Douglas, 2011; White, 2011).
- This article provides an overview on prescription drug abuse and highlights a number of related legislative bills introduced during the 112th Congress in response to this growing epidemic. Prescription drug abuse has emerged as the nation’s fastest growing drug problem. Although prescription drugs have been used effectively and appropriately for decades, deaths from prescription pain medicine in particular have reached epidemic proportions. Bills related to prescription drug abuse introduced during the 112th Congress focus on strengthening provider and consumer education, tracking and monitoring prescription drug abuse, improving data collection on drug overdose fatalities, combating fraud and abuse in Medicare and Medicaid programs, reclassifying drugs to make them more difficult to prescribe and obtain, and enforcing stricter penalties for individuals who operate scam pain clinics and sell pain pills illegitimately.
- The increasing interconnectedness of the world and the factors that affect health lay the foundation for the evolving practice of global health diplomacy. There has been limited discussion in the nursing literature about the concept of global health diplomacy or the role of nurses in such initiatives. A discussion of this concept is presented here by the members of a Task Force on Global Health Diplomacy of the American Academy of Nursing Expert Panel on Global Nursing and Health (AAN EPGNH). The purpose of this article is to present an integrative review of literature on the concept of global health diplomacy and to identify implications of this emerging field for nursing education, practice, and research.
- The RWJF/AARP National Campaign for Action established a goal of establishing Action Coalitions in every state by 2012. Last year, a small Steering Committee formed in Nebraska and used two conceptual models to guide the organization and development of its Action Coalition. The purpose of this article is to present the Internal Coalition Outcome Hierarchy (ICOH) model that guided development of partnership and coalition building. The second model, Determining Program Feasibility, provided a framework for data collection and analysis to identify the opportunities and challenges for strategic program planning to accomplish identified key priorities for Nebraska.
- There has been a recent resurgence of interest in women's health as evidenced by several federal and international policy-shaping reports that will impact women's health services. These reports include the 2010 Affordable Care Act, the formation of the National Prevention Council and Strategy, the 2011 IOM report on clinical preventives services for women, and the World Health Organization strategic plan for 2010-2015. In this paper, we summarize and discuss these reports and discuss implications of enacting the suggested health policies.
- From July 1999 to July 2000, I was the American Academy of Nursing Senior Scholar at the Agency for Healthcare Research and Quality (AHRQ) (formerly the Agency for Healthcare Policy and Research). During this time, I spent half time at the agency, alternating weeks at the agency and the University of Michigan. My goals for this experience included the following: increasing emphasis on occupa-tional health issues and concerns at the agency, promoting collaboration between the agency and the National Institute for Occupational Safety and Health (NIOSH), and gaining a greater understanding of the activities and operations of the agency.
- The letter from Secretary Shalala appointing me to the Secretary's Advisory Committee on Genetic Testing (SACGT) was dated April 12, 1999. The date would have been my sister's 50th birthday, except my sister had died of cystic fibrosis shortly before her sixth birthday. A brother, who had been born a year before me, had died at age 2 weeks, and it was only after my sister's diagnosis that we learned his meconium ileus also had been due to cystic fibrosis. Clearly, genetic illness has had a large impact on my family.
- Twenty-five outstanding nurses benefitted from a Helene Fuld Foundation grant given in 1998 to the American Academy of Nursing (AAN) and the American Nurses Foundation's (ANF) Institute for Nursing Leadership (INL). The Policy Leadership Institute was provided by the George Mason University's Center for Health Policy, Research and Ethics during the Annual Health Policy Institute June 5-13, 2000. Through a collaborative partnership between the INL and the Center for Health Policy, Research and Ethics, we are pleased to announce that 35 graduates have completed this program since its inception in 1999.